You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A brief iPad based screening measure for HIV associated neurocognitive disorders
SBC: Digital Artefacts LLC Topic: 105Despite significance advances in anti retroviral treatments HIV associated neurocognitive disorder HAND remains prevalent and can affect a broad range of everyday activities An effective brief cognitive screen that could be implemented in busy HIV clinics where clinicians have limited time to provide care for patients with complex medical psychiatric and cognitive conditions has the poten ...
STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Active Radiation Shield
SBC: GLOYER-TAYLOR LABORATORIES INC Topic: T301DEC-Shield technology offers the means to generate electric power from cosmic radiation sources and fuse dissimilar systems and functionality into a structural component to create a Multi-functional Structure (MFS). DEC-Shield integrated into MFS technology can be used to generate electric power and provide radiation protection in a space vehicle; even maximizing that protection by spreading the ...
STTR Phase I 2016 National Aeronautics and Space Administration -
Active Radiation Shield
SBC: GLOYER-TAYLOR LABORATORIES INC Topic: T301In the Phase I effort, Gloyer-Taylor Laboratories LLC (GTL) verified the feasibility of generating power from space particle radiation. This effort successfully demonstrated electrical power production from a particle radiation source using an initial proof-of-concept device. The effort also identified a second approach that has the potential for even better power generation and offers enhanced ...
STTR Phase II 2017 National Aeronautics and Space Administration -
An Additive Manufacturing Technique for the Production of Electronic Circuits
SBC: Morningbird Media Corporation Topic: T1204The proposed 9-month research project aims for the development of additive manufacturing techniques for the creation of electronic devices. It will develop an innovative additive manufacturing technique that combines the ink-based printing with laser melting technology to directly print a three-dimensional (3D) system with built-in electrical properties and functioning as an electronic device. Th ...
STTR Phase I 2016 National Aeronautics and Space Administration -
An Automated Patient Chart Error Detection System for Radiation Therapy
SBC: Infondrian LLC Topic: 101Project Summary Abstract Every year approximately severe mistreatments happen in radiation therapy Radiation therapy lawsuits rank in the top third of all medical specialties with an average of $ per claim settled or litigated The current method for detecting treatment errors is by a weekly patient chart check where each treatment record is manually reviewed on a weekly basis Thi ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A New Prostate Cancer Treatment to Improve Outcomes and Reduce Side-effects
SBC: PXALPHA, L.L.C. Topic: 102PROJECT SUMMARY ABSTRACT Among men prostate cancer is the most common non skin cancer and second leading cause of cancer death with over new diagnoses expected in Approximately of men will be diagnosed with prostate cancer in their lifetime Current treatment options for prostate cancer however have sub optimal incidences of side effects that have a significant impact on pa ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A simple and effective diagnostic test for gastrointestinal bleeding to improve patient outcomes
SBC: CUMBERLAND PHARMACEUTICALS, INC. Topic: 300DESCRIPTION provided by applicant Problem Lower gastrointestinal bleeding is a significant medical problem in the United States accounting for more than hospital admissions and tens of billions of dollars of healthcare spending annually It is common for bleeding from a single site to stop and restart multiple times The three modalities now used to diagnose and locate gastrointestina ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Commercialization of a Novel Therapeutic for Alzheimer's Disease
SBC: CoPlex Therapeutics, LLC Topic: NIAABSTRACT Traditional mon therapeutictarget driven approaches to drug development for Alzheimer s diseaseADare becoming increasingly expensive and in many cases disappointingly unsuccessfulBased on preliminary in vitro and in vivo studies we have identified a novel small moleculemethyldimethyloxodihydrobenzo cnaphthyridinecarboxylateBNCthat significantly decreases neuroinflammation and production o ...
STTR Phase II 2017 Department of Health and Human ServicesNational Institutes of Health -
Composite Repair System
SBC: GLOYER-TAYLOR LABORATORIES INC Topic: T1202GTL has developed an innovative composite repair methodology known as the Composite Repair System (CRS). In this phase I effort, CRS is being developed for the repair of damaged induced in thin-laminate composite cryotanks. In applying CRS to damaged composite structures, the required level of structural capacity is recovered to within a predetermined percentage of its original performance after ...
STTR Phase I 2017 National Aeronautics and Space Administration -
Developing a novel adjuvant system for therapeutic vaccines against lung cancer
SBC: FasCure Therapeutics LLC Topic: 102DESCRIPTION provided by applicant Therapeutics is focused on the development of adjuvant systems with desired immune activities for targeted indications The Companyandapos s immune stimulatory adjuvant platform builds on combinatorial use of immune agonists with distinct immune targets and mechanisms of action for the generation of therapeutic immune responses Critical to this platform techno ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health